JECTEEL Trademark

Trademark Overview

On Wednesday, April 22, 2009, a trademark application was filed for JECTEEL with the United States Patent and Trademark Office. The USPTO has given the JECTEEL trademark a serial number of 79070232. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, April 22, 2019. This trademark is owned by sanofi-aventis. The JECTEEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for cancer prevention and treatment
jecteel

General Information

Serial Number79070232
Word MarkJECTEEL
Filing DateWednesday, April 22, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, April 22, 2019
Registration Number3742691
Registration DateTuesday, January 26, 2010
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 10, 2009

Trademark Statements

Goods and ServicesPharmaceutical products for cancer prevention and treatment
Translation of Words in MarkThe wording "JECTEEL" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, September 2, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party Namesanofi-aventis
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party Namesanofi-aventis
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, November 15, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, November 15, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, June 16, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, May 11, 2017TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, May 11, 2017INVALIDATION PROCESSED
Tuesday, May 2, 2017TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, September 2, 2016CANCELLED SECTION 71
Saturday, July 21, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, December 10, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, December 23, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, July 10, 2010FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 24, 2010FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 24, 2010FINAL DISPOSITION PROCESSED
Monday, April 26, 2010FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 26, 2010REGISTERED-PRINCIPAL REGISTER
Tuesday, November 10, 2009OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 10, 2009PUBLISHED FOR OPPOSITION
Saturday, October 3, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, October 2, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 23, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 23, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 23, 2009ASSIGNED TO LIE
Monday, September 21, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 21, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, August 28, 2009REFUSAL PROCESSED BY IB
Monday, August 3, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, August 3, 2009REFUSAL PROCESSED BY MPU
Friday, July 31, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, July 30, 2009NON-FINAL ACTION WRITTEN
Tuesday, July 28, 2009APPLICATION FILING RECEIPT MAILED
Friday, July 24, 2009ASSIGNED TO EXAMINER
Friday, July 24, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 23, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

jecteel treatment prevention cancer products pharmaceutical